Scott L. Burrows - 02 Mar 2023 Form 4 Insider Report for Arcutis Biotherapeutics, Inc. (ARQT)

Reporting relationship: Chief Financial Officer
Issuer ticker: ARQT
Reported as of: 02 Mar 2023
Net transaction value: $0
SEC form: 4
Accepted by SEC: 06 Mar 2023, 17:58:30 UTC
Prior SEC filing: 02 Mar 2023
Next SEC filing: 08 Mar 2023
Source filing: View source filing
Reporting owner signature: /s/ Scott L. Burrows

Key filing fact

Scott L. Burrows filed Form 4 for Arcutis Biotherapeutics, Inc. (ARQT) on 06 Mar 2023.

Key facts

This page summarizes Scott L. Burrows's Form 4 filing for Arcutis Biotherapeutics, Inc. (ARQT).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 06 Mar 2023, 17:58.

Change

Previous filing in this sequence was filed on 02 Mar 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ARQT transaction

Common Stock

Award

Transaction value: $0
Shares: +21,000
Change %: +55%
Price: $0.000000
Shares after: 59,406
Date: 02 Mar 2023
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ARQT transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +55,800
Change %
Price: $0.000000
Shares after: 55,800
Date: 02 Mar 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 55,800
Exercise price: $15.82
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon vesting. 25% of the RSUs vest annually on March 2 of each year, beginning March 2, 2024, subject to the Reporting Person's continued service to the Issuer.

Footnote F2

1/48th of the shares subject to the option vest on each monthly anniversary measured from March 2, 2023 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer.